U.s.a. Version Canada Version China Version

Latest News from Copan

Beckman Coulter Diagnostics and COPAN Announce Expansion of Distribution Agreement for Automated Sample Processing Systems and Digital Microbiology

BREA, CALIF. and MURRIETA, CALIF. – (August 10, 2015) – Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and COPAN a company committed to innovation in the field of pre:analytics, today announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their Distribution Agreement that expands their relationship into new products and geographic territories.


Two New US Patents Protect COPAN Invention of Flocked Swabs

Brescia, Italy, April 23, 2015 – The US Patent Office recently granted two additional patents to COPAN regarding flocked swabs. The patent numbers are US 8,979,784 and US 9,011,358, issued on 17th March 2015 and 21st April 2015 respectively. These two patents, are continuations of previous applications related to the flocked swab technology, proudly invented and developed by Copan and dedicated to the collection of biological specimens.


Strategic alliance between bioMérieux and COPAN to automate clinical microbiology laboratories and enhance their operational efficiency

Marcy l'Etoile (France) - Brescia (Italy), January 9, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, and COPAN, a leading manufacturer of innovative pre-analytic solutions, are pleased to announce that they have signed a strategic partnership in clinical microbiology laboratory automation. Under the terms of the agreement, COPAN has granted distribution rights for its automated platforms (including the WASP® Walk-Away Specimen Processor and the WASPLabTM solutions which automate microbiology laboratory tasks and provide digital imaging and analysis) to bioMérieux. This agreement allows bioMérieux to speed up deployment of its "FMLA® - Lab Efficiency*" vision for the automation and enhanced operational efficiency of clinical microbiology labs. In this field, the two companies also plan to collaborate in particular for the development of innovative clinical microbiology diagnostic solutions.


COPAN Group Announces the Untimely Death of Its Beloved CEO and General Manager, Daniele Triva

Brescia, Italy, September 2nd, 2014– COPAN Group announces with great sadness that, on July 30th, 2014, its beloved, charismatic and eclectic leader, Daniele Triva passed away at his home in Italy, after a seven-month battle with Esophageal Gastric cancer. Daniele was 54 years old and leaves behind his wife and four children, his sister and family and a legacy of technological innovation in the field of pre-analytics.

September, 2014 DOWNLOAD ARTICLE

Copan announces global partnership with Metasystems GmbH for the integration of culture plates and gram stain images for enhanced digital microbiology

COPAN and MetaSystems GmbH are pleased to announce they have signed a global and exclusive agreement for the integration of automatic microscopy slide scanning system, provided by MetaSystems, with WASPLab™. This partnership provides current and future COPAN customers the option to implement in their microbiology laboratory a fully automated system for the acquisition of microscopy images of Gram slides (under the brand Metafer) seamlessly integrated with the WASPLab™ environment.


US Patent Office Grants COPAN Invention of FLOQSwab™

The US Patent Office has awarded COPAN the much awaited patent for its FLOQSwab™ invention for collection and transfer of biological samples. This grant, deriving from a very thorough and careful examination, strengthens COPAN’s patent portfolio around the World for its flocked swab invention. COPAN’s revolutionary invention has now been awarded patents in every Country where it had been filed.

December 22, 2011 DOWNLOAD ARTICLE

COPAN Flock Technologies Launches New Website in Chinese to Serve Burgeoning IVD and Medical Device Manufacturers in China

COPAN has proudly announced this week the launch of the Chinese version of the Copan Flock Technologies website. The Chinese website aims at better serving COPAN’s growing customer base in the IVD and Medical Device Manufacturers market in China.

December 5, 2011 DOWNLOAD ARTICLE

Revisiting Best Practices for Respiratory Virus Testing as Flu Season Draws Near

In the September, 2011 Journal of Clinical Microbiology, COPAN’s FLOQSwab™ were cited as an important advance in testing for respiratory viruses. The JCM article “Current Best Practices for Respiratory Virus Testing” by Christine Ginocchio and Alexander MacAdam considers current issues in diagnostic testing for respiratory viruses including best methods for detection, sample handling and testing for antiviral resistance. The goal of the discussion, by the authors and the working group which contributed to the article, was to come to a consensus on the best practices for respiratory virus testing and to raise questions for further consideration.

October 10, 2011 DOWNLOAD ARTICLE

COPAN WASP® Lands at Prestigious Boston Medical Center

Boston Medical Center (BMC) in Boston Massachusetts, USA, recently took delivery of their long-awaited WASP® (Walk Away Specimen Processor), which includes a Gram SlidePrep™ Module. The acquisition was concomitant with the inauguration of BMC’s new clinical laboratory facilities, and BMC’s ongoing efforts to optimize patient care by consolidating resources and improving workflow within the lab.

October 3, 2011 DOWNLOAD ARTICLE

Winner of COPAN’s “I Love COPAN FLOQSwab™” Promotion is Announced

The winner of the “I love COPAN FLOQSwab™ Promotion” has been announced. COPAN ran the promotion from March 2011 to May 2011, and it was publicized in different magazines and industry events. The winner's name was randomly selected from all the entries, as she became the winner of a trip for two to Italy. Participants were asked to tell us why they love COPAN FLOQSwab™, and we were pleased with the tremendous number of responses received. To see what others are saying, go to http://www.iloveflockedswabs.com


COPAN Announces Workshop on Automated Specimen Processing, Digital Workup and Reporting in Microbiology during AACC Clinical Lab Expo

COPAN will present changes in Microbiology and what they mean for automated specimen processing, especially related to revolutionary remote Bacteriology through WASPLab™ image acquisition and analysis. The presentation will examine the dramatic impact on microbiology efficiency and turn-around-time for results of the ability to view, workup, and report cultures remotely from anywhere with internet access. Registration still open. Register today


China Grants COPAN Patent for FLOQSwab™

COPAN announced that it has received the Chinese patent for its invention of FLOQSwab™, FLOQSwabs™, for collection and transfer of biological samples. The Chinese FLOQSwab™ patent is the latest addition to a growing number of patents held by COPAN across the world for the use of FLOQSwab™ for collection and transfer of biological samples, including a European patent that covers several countries (N°1608268), an Australian patent (N°2004226798), a Canadian patent (N°2515205), a Japanese patent (2007-523663) and New Zealand patent (N°541560).


COPAN Announces Strategic Global Distribution Partnership with Siemens

COPAN announced a strategic partnership with Siemens for the global distribution of COPAN WASP®: Walk-Away Specimen Processor in New Orleans, Louisiana, during the ASM’s 111th General Meeting. This distribution agreement is particularly exciting for the US hospital market as it merges Siemens’ strong reputation in Microbiology and COPAN’s innovation in pre-analytics.


COPAN Announces the Launch of WASPLab

COPAN is proud to announce the worldwide launch of WASPLab™ , a barcode driven and conveyor-connected specimen processing system, which utilizes robotic plate management to automate specimen workflow in Microbiology. The unveiling of the system will be in Milan, during the 21st ECCMID General Meeting from May 7 to May 10, 2011, and in New Orleans, Louisiana, during the ASM’s 111th General Meeting from May 21 to May 24, 2011.


COPAN Files New Patents Following the Development of High Nucleic Acid Yield FLOQSwab™

Even though FLOQSwabs release almost the entire sample, nucleic acid has a tendency to be sticky and some residue can still attach to swab fibers. This risk is eliminated with COPAN’s latest discovery in fiber treatment for FLOQSwab™. This demonstrable improvement is now the subject of a series of new patent applications by Copan in the USA and in other countries around the world.

December 16, 2010 DOWNLOAD ARTICLE

COPAN Debuts WASPLab™ Incubator at MEDICA

WASPLab™ Incubator was showcased at MEDICA in Dusseldorf, Germany to great reactions from the attendees. The unveiling of the newest WASP® module, WASPLab™ Incubator, is just one more example of the company’s constant innovation and dedication to serving the needs of the Microbiology community.

December 6, 2010 DOWNLOAD ARTICLE

FLOQSwabs™ by COPAN Conclusively Yield Better Accuracy and Detection of S. aureus than Traditional Fiber Swabs

A recent study conducted at University Hospital of Saint-Etienne in France unambiguously concluded that in comparison to traditional rayon fiber swabs, the use of FLOQSwabs™ by Copan leads to more accurate results in the rapid screening for S. aureus nasal carriage.

November 16, 2010 DOWNLOAD ARTICLE

COPAN Secures Japanese Patent for its Flocked Swab Innovation

COPAN announced this week that it has received the Japanese patent for the invention of FLOQSwab™, FLOQSwabs™, for collection and transfer of biological samples. The Japanese patent for COPAN’s FLOQSwab™ is the latest addition to a growing number of patents held by COPAN across the world for the use of FLOQSwab™ for collection and transfer of biological samples.

September 10, 2010 DOWNLOAD ARTICLE

Copan Redefines Automated Specimen Processing with Groundbreaking New Features

Murrieta, CA – June 15th, 2010 – Copan unveiled new groundbreaking features of its Walk- Away Specimen Processor (WASP®) while attending the 110th General Meeting for the American Society for Microbiology (ASM) in San Diego, California this past May. Copan’s line of automation was introduced to the market in 2008 with the launch of the WASP®, a revolutionary system for automatic planting and streaking of all microbiology samples...


Copan Installs Milestone 30th Walk-Away Specimen Processor (WASP®)

Murrieta, CA – June 3rd, 2010 – Copan is proud to announce the 30th placement of a Walk-Away Specimen Processor (WASP®), at Eastern Health, Newfoundland, in Canada. The WASP® is a revolutionary instrument used for automatically planting and streaking bacteriology samples...


Copan Secures Additional Patent for its Flocked Swab Innovation

Murrieta, CA – May 13, 2010 – Copan was recently granted the Australian patent for its line of FLOQSwab™. Copan is the original inventor of flocked swab technology and introduced the first FLOQSwab™ to the market in 2004...


Copan Diagnostics Inc. Takes Innovation in Preanalytics a Step Further, Developing Automation for Gram Slide Preparation

Murrieta, CA – March 23, 2010 – In its endeavors to continuously make innovative strides in preanalytics and clinical microbiology, Copan Diagnostics announced this week that they will launch a groundbreaking new addition to its Walk-Away Specimen Processor, WASP® and to its line of automation. WASP® will now have anoptional automatic Gram slide preparation module...


Copan Diagnostics, Inc. Unveils Redesigned Website for Improved Customer Experience

Murrieta, CA – January 3, 2010 – Copan Diagnostics, Inc. has recently launched a totally new website as the company continues to grow and diversify. In the spirit of innovation and creativity, Copan’s new site is filled with informational tools, such as scientific studies, educational training videos, brochures, news and events, technical information, and more. The main focus of Copan Diagnostics’ new website is an improved user experience...

January 3, 2010 DOWNLOAD ARTICLE

ASM recommends Nasopharyngeal FLOQSwab™ as the Specimen of Choice for Influenza A Testing (including H1N1)

Murrieta, California, October 27th, 2009 - Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1...

October 27, 2009 DOWNLOAD ARTICLE

Copan Announces Multimillion Expansion for US Pipet Manufacturing Operations

Murrieta, California, August 27th, 2009 - Despite tough economic times, Copan is proud to announce the expansion of its US operations. Copan Diagnostics, Inc. is undertaking a new multimillion dollar investment project to bring plastic transfer pipet and additional medical device manufacturing operations to its facility in Murrieta, California...

August 27, 2009 DOWNLOAD ARTICLE

CDC Recommends Copan - Manufactured Viral Transport Media and FLOQSwab™ for Collection of H1N1 (Swine Flu) Virus

As of May 5th, 2009, the World Health Organization, has officially reported 1124 cases of Influenza A (H1N1) infection in 21 different countries. As the situation with the novel H1N1 (Swine Flu) virus continues to evolve, the Centers for Disease Control and Prevention (CDC) continue to update their document...


Copan Ramps Up Production of Kits for Collection of Nasopharyngeal Samples to Detect Swine Flu Virus

As the World Health Organization raises the current level of the influenza pandemic alert from phase 4 to 5, physicians’ offices, hospital clinics, and emergency rooms prepare to accommodate patients with symptoms of respiratory viral infection...



July 30 - August 1, 2013
AACC - Clinical Lab Expo
Houston, TX – USA

September 11-14, 2013
ECV - European Congress of Virology
Lyon, France

Click here for complete
list of events 


Evaluation of Swabs, Transport Media, and Specimen Transport Conditions for Optimal Detection of Vir
The study cited in the article the use of Copan products shown as acceptable collection and transport devices for use during a pandemic for PCR testing.

Want more Studies?
Click here to find more